COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiency [0.03%]
COVID-19和X连锁无丙种球蛋白血症(XLA)-单基因抗体缺乏的启示
Mark J Ponsford,Benjamin M J Shillitoe,Ian R Humphreys et al.
Mark J Ponsford et al.
Purpose of review: The clinical outcomes from COVID-19 in monogenic causes of predominant antibody deficiency have pivotal implications for our understanding of the antiviral contribution of humoral immunity. This review ...
COVID-19 in complex common variable immunodeficiency patients affected by lung diseases [0.03%]
患有肺部疾病的复杂型共同变量免疫缺陷病患者中的COVID-19
Cinzia Milito,Valentina Soccodato,Stefania Auria et al.
Cinzia Milito et al.
Purpose of review: In the general population, the risk of severe COVID-19 is associated with old age, male sex, hypertension, obesity and chronic diseases. Chronic lung diseases are listed as additional risk factors for h...
Lennart Hammarström,Harold Marcotte,Antonio Piralla et al.
Lennart Hammarström et al.
Purpose of review: To provide an update of the current state of antibody therapy for Severe Acute Respiratory Syndrome Coronavirus 2 infection that has progressed immensely in a very short time period. ...
Amélia Ribeiro,Rita Aguiar,Mário Morais-Almeida
Amélia Ribeiro
Purpose of review: As of June 2021, coronavirus disease 2019 (COVID-19) exceeded 180 million reported cases and was responsible for almost 4 million deaths globally. Asthma affects approximately 262 million people worldwi...
Tomas Milota,Zuzana Strizova,Jitka Smetanova et al.
Tomas Milota et al.
Purpose of review: Antisevere acute respiratory syndrome-corona virus 2 (SARS-CoV-2) vaccines may provide prompt, effective, and safe solution for the COVID-19 pandemic. Several vaccine candidates have been evaluated in r...
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity [0.03%]
宿主在严重急性呼吸系统综合征冠状病毒2型感染下防御和疾病的病理机制：来自先天性免疫缺陷的启示
Stuart G Tangye,Giorgia Bucciol,Isabelle Meyts
Stuart G Tangye
Purpose of review: The severe acute respiratory syndrome (SARS)-coronavirus 2 (CoV2)/COVID-19 pandemic has reminded us of the fundamental and nonredundant role played by the innate and adaptive immune systems in host defe...
Peter Socrates Creticos
Peter Socrates Creticos
Purpose of review: Sublingual tablet immunotherapy has been demonstrated to be effective for allergies induced by exposure to grass, ragweed, specific trees (Japanese Cedar; birch homologous tree mix), and house dust mite...
Harold S Nelson
Harold S Nelson
Purpose of review: European and US allergists generally do not agree on the approach to subcutaneous allergy immunotherapy in patients with multiple allergies. The North American approach is to treat with a mixture that c...
Jennifer A Dantzer,Robert A Wood
Jennifer A Dantzer
Purpose of review: To review the most relevant studies in the advancing field of omalizumab in allergen immunotherapy. Recent findings: ...
Alessandra Longo,Valeria Longo,Paolo Colombo
Alessandra Longo
Purpose of review: Allergen immunotherapy is the only recognized causal treatment for allergic disease that modulates the immune system toward a tolerogenic or desensitized state. Allergens or their derivative preparation...